These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16205857)

  • 21. Patent foramen ovale and cryptogenic stroke. A critical review.
    Ballerini L; Cifarelli A; Ammirati A; Gimigliano F
    J Cardiovasc Med (Hagerstown); 2007 Jan; 8(1):34-8. PubMed ID: 17255814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patent foramen ovale and cerebrovascular diseases.
    Desai AJ; Fuller CJ; Jesurum JT; Reisman M
    Nat Clin Pract Cardiovasc Med; 2006 Aug; 3(8):446-55. PubMed ID: 16874357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale.
    Schuchlenz HW; Weihs W; Berghold A; Lechner A; Schmidt R
    Int J Cardiol; 2005 May; 101(1):77-82. PubMed ID: 15860387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patent foramen ovale, atrial septal aneurysm, and recurrent stroke.
    Corboy JR
    N Engl J Med; 2002 Apr; 346(17):1331-2; author reply 1331-2. PubMed ID: 11973372
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
    Windecker S; Wahl A; Nedeltchev K; Arnold M; Schwerzmann M; Seiler C; Mattle HP; Meier B
    J Am Coll Cardiol; 2004 Aug; 44(4):750-8. PubMed ID: 15312853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Patent foramen ovale and stroke].
    Meier JM; Delabays A; Girod G; Eeckhout E
    Arch Mal Coeur Vaiss; 2004 Oct; 97(10):987-93. PubMed ID: 16008176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age is not a predictor of patent foramen ovale with right-to-left shunt in patients with cerebral ischemic events.
    Yahia AM; Shaukat A; Kirmani JF; Qureshi AI
    Echocardiography; 2004 Aug; 21(6):517-22. PubMed ID: 15298687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombotic therapy for stroke in young adults.
    Payne JR; Coull B
    J Thromb Thrombolysis; 2005 Oct; 20(2):127-32. PubMed ID: 16205861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patent foramen ovale and cryptogenic cerebral infarction.
    McGaw D; Harper R
    Intern Med J; 2001; 31(1):42-7. PubMed ID: 11478356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patent foramen ovale with atrial septal aneurysm may contribute to white matter lesions in stroke patients.
    Ueno Y; Shimada Y; Tanaka R; Miyamoto N; Tanaka Y; Hattori N; Urabe T
    Cerebrovasc Dis; 2010; 30(1):15-22. PubMed ID: 20424440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Thrombophilia and patent foramen ovale in young stroke patients].
    Carod-Artal FJ; Vilela Nunes S; Portugal D
    Neurologia; 2006 Dec; 21(10):710-6. PubMed ID: 17106824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke.
    Thanopoulos BV; Dardas PD; Karanasios E; Mezilis N
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):741-6. PubMed ID: 17039525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Patent foramen ovale, aneurysm of the interatrial septum and cerebral ischemic complication].
    Mas JL
    Ann Cardiol Angeiol (Paris); 1996 Nov; 45(9):531-7. PubMed ID: 9033708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of cryptogenic stroke.
    Finsterer J
    Acta Neurol Belg; 2010 Jun; 110(2):135-47. PubMed ID: 20873443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial experience with a transcatheter septal closure system for secondary stroke prevention in patients with interatrial septal defects.
    Silverman IE; Kiernan FJ; Kelsey AM; Brakoniecki JJ; Kazi FA; Dougherty JE; Boden WE; McKay RG
    Conn Med; 2003 Mar; 67(3):135-44. PubMed ID: 12687787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patent foramen ovale and stroke: closure by further randomized trial is required!
    Donnan GA; Davis SM
    Stroke; 2004 Mar; 35(3):806. PubMed ID: 14963267
    [No Abstract]   [Full Text] [Related]  

  • 38. Cryptogenic Stroke with a Patent Foramen Ovale: Medical Therapy, Percutaneous Intervention, or Surgery.
    Bedeir K; Volpi J; Ramlawi B
    J Card Surg; 2016 Mar; 31(3):156-60. PubMed ID: 26785821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous transcatheter closure of patent foramen ovale.
    Chatterjee T; Ritz A; Rehders TC; Ince H; Kische S; Petzsch M; Nienaber CA
    Minerva Cardioangiol; 2006 Feb; 54(1):31-9. PubMed ID: 16467740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How to prevent stroke recurrence in patients with patent foramen ovale: anticoagulants, antiaggregants, foramen closure, or nothing?
    Nendaz M; Sarasin FP; Bogousslavsky J
    Eur Neurol; 1997; 37(4):199-204. PubMed ID: 9208257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.